HomeGreater Than Icon
Mutual FundsGreater Than Icon
Compare Mutual FundsGreater Than Icon
Nippon India Pharma Fund - Direct (G) vs Nippon India Power & Infra Fund - Direct (G)

Nippon India Pharma Fund - Direct (G) vs Nippon India Power & Infra Fund - Direct (G)

stock1

Nippon India Pharma Fund - Direct (G)

9.45%

stock2

Nippon India Power & Infra Fund - Direct (G)

-9.14%

Graph not available
Graph not available

About Fund

Deutsche Bank AG

Karvy Computershare Pvt. Ltd.

Deutsche Bank AG

Karvy Computershare Pvt. Ltd.

Very High Risk

5000

8569.15

1.12

575.8395

January 1, 2013

1

Very High Risk

5000

7619.74

1.12

366.5045

January 1, 2013

1

21.32 %

25.57 %

9.45 %

32.63 %

32.37 %

-9.14 %

Sailesh Raj Bhan

MBA (Finance), CFA.

Mr.Bhan is an MBA with specialization in Finance and CFA. Has over 9 Yrs. of experience in Equity Securities Research & Sequeir Investment Pvt. Ltd. for 5 years and with Emkay Share & stock Broker Pvt. Ltd. for 2 years.

Rahul Modi

Masters in Finance and Investment from Nottingham Business School (UK) - 2007 BCOM (H) from Calcutta University - 2005

Over 17 years of experience From August 19, 2024 onwards Fund Manager & Research Analyst, NAM India February 08, 2023 - August 18, 2024 Nippon India Mutual Fund - Buy Side Analyst in equities team - Covering Power, Industrials, Defence, Infrastructure and logistics October 2017 - January 2023 ICICI Securities - VP - Sell Side analyst covering Power, Capital Goods and Infrastructure September 2012 - October 2017 Antique Stock Broking - VP - Sell side analyst covering Power & Infrastructure

Sanjay Doshi

ACA, MBA (Finance), Cleared CFA Level III

Over 11 years of experience in capital market From January 02, 2017: RNLAM : Fund Manager - Equity February 01, 2011 to January 01, 2017 RNLAM, Sr. Analyst Equity Investment August 2007 to December 2010 Macquarie Capital Securities (India) Pvt Ltd - Analyst Equity Research September 2005 to July 2007 JP Morgan Services (India) Pvt Ltd - Associate Convertible Bonds Research

Sunil Singhania

B.com, CFA., and FCA

Prior to joining Reliance AMC, has worked with Advani Share Brokers Pvt. Ltd. as Director - Institutional Sales & Research for 6 years and with Motisons Securities Pvt. Ltd. for 3 years.

Get your FAQs right

When comparing Nippon India Pharma Fund - Direct (G) vs Nippon India Power & Infra Fund - Direct (G), consider factors such as historical performance, expense ratios, investment strategy, risk level, and the fund manager's credibility. Moreover, look at asset allocation and how each fund fits your investment goals.
Yes, you can invest in both Nippon India Pharma Fund - Direct (G) and Nippon India Power & Infra Fund - Direct (G) at the same time. This can help diversify your portfolio and balance risk, provided the fund manager's investment strategies streamline each other.
While comparing Nippon India Pharma Fund - Direct (G) and Nippon India Power & Infra Fund - Direct (G), the portfolio turnover ratio indicates how frequently assets within the fund are bought and sold. A high turnover may lead to higher transaction costs and tax implications, while a low turnover ratio indicates a buy-and-hold strategy.
Yes, you can typically switch between Nippon India Pharma Fund - Direct (G) and Nippon India Power & Infra Fund - Direct (G), subject to the fund's policies and any applicable fees. It is important to consider potential tax implications and the timing of your switch.
Yes, you can compare Nippon India Pharma Fund - Direct (G) and Nippon India Power & Infra Fund - Direct (G) based on their dividend payouts. Look at dividends profit, consistency, and growth, as these factors can influence your overall return on investment.

Join the Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions